Guggenheim Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.3M | Buy |
577,945
+13,801
| +2% | +$792K | 0.21% | 90 |
|
|
2026
Q1 | $34.2M | Sell |
564,144
-18,353
| -3% | -$1.07M | 0.27% | 79 |
|
|
2025
Q4 | $31.4M | Sell |
582,497
-60,635
| -9% | -$2.92M | 0.23% | 89 |
|
|
2025
Q3 | $29M | Sell |
643,132
-26,319
| -4% | -$1.23M | 0.21% | 94 |
|
|
2025
Q2 | $31M | Buy |
669,451
+1,944
| +0.3% | +$95.4K | 0.25% | 86 |
|
|
2025
Q1 | $40.7M | Sell |
667,507
-56,169
| -8% | -$3.27M | 0.37% | 54 |
|
|
2024
Q4 | $40.9M | Buy |
723,676
+2,398
| +0.3% | +$134K | 0.33% | 58 |
|
|
2024
Q3 | $37.3M | Buy |
721,278
+23,927
| +3% | +$1.12M | 0.26% | 71 |
|
|
2024
Q2 | $29M | Buy |
697,351
+51,188
| +8% | +$2.29M | 0.21% | 90 |
|
|
2024
Q1 | $35M | Buy |
646,163
+106,790
| +20% | +$5.44M | 0.25% | 80 |
|
|
2023
Q4 | $27.7M | Buy |
539,373
+29,111
| +6% | +$1.53M | 0.21% | 93 |
|
|
2023
Q3 | $29.6M | Sell |
510,262
-24,647
| -5% | -$1.51M | 0.25% | 73 |
|
|
2023
Q2 | $34.2M | Buy |
534,909
+59,459
| +13% | +$3.99M | 0.27% | 66 |
|
|
2023
Q1 | $33M | Sell |
475,450
-28,567
| -6% | -$2.01M | 0.28% | 63 |
|
|
2022
Q4 | $36.3M | Buy |
504,017
+5,939
| +1% | +$448K | 0.32% | 59 |
|
|
2022
Q3 | $35.4M | Sell |
498,078
-7,338
| -1% | -$532K | 0.32% | 58 |
|
|
2022
Q2 | $38.9M | Sell |
505,416
-74,520
| -13% | -$5.68M | 0.31% | 58 |
|
|
2022
Q1 | $42.4M | Buy |
579,936
+31,269
| +6% | +$2.1M | 0.25% | 66 |
|
|
2021
Q4 | $34.2M | Buy |
548,667
+64,309
| +13% | +$3.77M | 0.18% | 112 |
|
|
2021
Q3 | $28.7M | Buy |
484,358
+7,678
| +2% | +$506K | 0.17% | 108 |
|
|
2021
Q2 | $31.9M | Buy |
476,680
+94,837
| +25% | +$6.18M | 0.19% | 94 |
|
|
2021
Q1 | $24.1M | Buy |
381,843
+94,715
| +33% | +$5.89M | 0.16% | 128 |
|
|
2020
Q4 | $17.8M | Buy |
287,128
+8,391
| +3% | +$516K | 0.11% | 170 |
|
|
2020
Q3 | $16.8M | Sell |
278,737
-21,210
| -7% | -$1.28M | 0.12% | 146 |
|
|
2020
Q2 | $17.6M | Buy |
299,947
+106,764
| +55% | +$6.39M | 0.14% | 139 |
|
|
2020
Q1 | $10.8M | Sell |
193,183
-92,851
| -32% | -$5.68M | 0.11% | 192 |
|
|
2019
Q4 | $18.4M | Buy |
286,034
+109,854
| +62% | +$6.29M | 0.14% | 161 |
|
|
2019
Q3 | $8.93M | Buy |
176,180
+13,005
| +8% | +$611K | 0.07% | 353 |
|
|
2019
Q2 | $7.4M | Sell |
163,175
-90,498
| -36% | -$4.22M | 0.06% | 400 |
|
|
2019
Q1 | $12.1M | Sell |
253,673
-79,790
| -24% | -$3.97M | 0.1% | 220 |
|
|
2018
Q4 | $17.3M | Buy |
333,463
+9,885
| +3% | +$531K | 0.15% | 134 |
|
|
2018
Q3 | $20.1M | Buy |
323,578
+13,727
| +4% | +$815K | 0.13% | 142 |
|
|
2018
Q2 | $17.1M | Sell |
309,851
-627,880
| -67% | -$33.9M | 0.11% | 171 |
|
|
2018
Q1 | $59.3M | Sell |
937,731
-64,733
| -6% | -$4.16M | 0.14% | 219 |
|
|
2017
Q4 | $61.4M | Buy |
1,002,464
+98,469
| +11% | +$6.16M | 0.15% | 213 |
|
|
2017
Q3 | $57.6M | Sell |
903,995
-130,265
| -13% | -$7.61M | 0.14% | 215 |
|
|
2017
Q2 | $57.6M | Buy |
1,034,260
+109,834
| +12% | +$5.98M | 0.15% | 201 |
|
|
2017
Q1 | $50.3M | Sell |
924,426
-16,957
| -2% | -$930K | 0.14% | 273 |
|
|
2016
Q4 | $55M | Buy |
941,383
+85,611
| +10% | +$4.68M | 0.16% | 170 |
|
|
2016
Q3 | $46.1M | Buy |
855,772
+55,941
| +7% | +$3.59M | 0.14% | 206 |
|
|
2016
Q2 | $58.8M | Sell |
799,831
-27,580
| -3% | -$1.95M | 0.18% | 102 |
|
|
2016
Q1 | $52.9M | Sell |
827,411
-66,872
| -7% | -$4.22M | 0.17% | 134 |
|
|
2015
Q4 | $61.5M | Sell |
894,283
-117,271
| -12% | -$7.75M | 0.18% | 111 |
|
|
2015
Q3 | $59.9M | Buy |
1,011,554
+136,299
| +16% | +$8.65M | 0.18% | 92 |
|
|
2015
Q2 | $58.2M | Buy |
875,255
+51,227
| +6% | +$3.38M | 0.14% | 154 |
|
|
2015
Q1 | $53.2M | Buy |
824,028
+29,646
| +4% | +$1.86M | 0.13% | 208 |
|
|
2014
Q4 | $46.9M | Buy |
794,382
+45,350
| +6% | +$2.56M | 0.12% | 258 |
|
|
2014
Q3 | $38.3M | Sell |
749,032
-22,416
| -3% | -$1.12M | 0.09% | 339 |
|
|
2014
Q2 | $37.4M | Sell |
771,448
-49,344
| -6% | -$2.43M | 0.09% | 340 |
|
|
2014
Q1 | $42.6M | Sell |
820,792
-47,049
| -5% | -$2.5M | 0.12% | 211 |
|
|
2013
Q4 | $46.1M | Sell |
867,841
-259,998
| -23% | -$13.2M | 0.14% | 159 |
|
|
2013
Q3 | $52.2M | Buy |
1,127,839
+254,939
| +29% | +$11.2M | 0.19% | 78 |
|
|
2013
Q2 | $39M | Buy |
+872,900
| New | +$37.9M | 0.16% | 95 |
|
Other funds holding BMY
Guggenheim Capital's BMY Position: Q2 2026 in Review
Guggenheim Capital increased its Bristol-Myers Squibb (BMY) stake by 2.4% in Q2 2026, buying an estimated $792K and bringing the position to 577,945 shares worth $33.3M. The position accounts for 0.21% of the portfolio, ranked #90.
Guggenheim Capital first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $61.5M in Q4 2015. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Guggenheim Capital held 577,945 shares of Bristol-Myers Squibb worth $33.3M as of Q2 2026.
- Guggenheim Capital bought 13,801 Bristol-Myers Squibb shares in Q2 2026, an estimated $792K.
- Bristol-Myers Squibb made up 0.21% of Guggenheim Capital's portfolio in Q2 2026, its #90 holding.
- Guggenheim Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Guggenheim Capital's Bristol-Myers Squibb position peaked at $61.5M in Q4 2015.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.